Lucey, Brendan P http://orcid.org/0000-0001-5400-825X
Holtzman, David M
Article History
First Online: 25 June 2015
Competing interests
: D.M.H. is a co-founder of C2N Diagnostics LLC and is on the scientific advisory boards of, or consults for, AstraZeneca, Genentech, Eli Lilly, Neurophage and C2N Diagnostics. Washington University receives research grants to the laboratory of D.M.H. from Cure Alzheimer's Fund, the JPB Foundation, Tau Consortium, Eli Lilly and C2N Diagnostics.